Skip to content

Drug interactions

Finerenone + Lomustine

Severity: Minor

Finerenone and Lomustine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Finerenone is a CYP3A4 substrate, and increased exposure raises the risk of hyperkalemia and renal effects. Lomustine is not an established CYP3A4 inhibitor, so any effect is theoretical.

What this interaction means in plain words

Finerenone and Lomustine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Finerenone belongs to Cardiovascular; Lomustine belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by lomustine, which is not well established.

What to do

Monitor serum potassium and renal function when starting or changing doses of either drug, adjusting finerenone as needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Finerenone and Lomustine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Finerenone with Lomustine?

MediHelp rates the interaction as minor. Finerenone and Lomustine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Finerenone is a CYP3A4 substrate, and increased exposure raises the risk of hyperkalemia and renal effects. Lomustine is not an established CYP3A4 inhibitor, so any effect is theoretical.

How serious is the interaction between Finerenone and Lomustine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function when starting or changing doses of either drug, adjusting finerenone as needed.

What other medicines interact with Lomustine?

MediHelp also lists interactions of Lomustine with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Lomustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in